Medicare Enrolled

Dr. Mitchell Ohara, DO

Cardiovascular Disease · Tampa, FL
Practice pattern: Cardiac & Electrophysiology— Practice combining cardiac and electrophysiology services
Low-engagement
3000 MEDICAL PARK DR STE 300, Tampa, FL 33613
8134979661
In practice since 2006 (19 years)
NPI: 1285705004 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ohara from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ohara? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ohara

Dr. Mitchell Ohara is a cardiovascular disease in Tampa, FL, with 19 years in practice. Based on federal Medicare data, Dr. Ohara performed 1,721 Medicare services across 1,056 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ohara received a total of $4,733 from 42 pharmaceutical and/or device companies across 192 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ohara is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 1,721 Medicare services$ $4,733 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,721
Medicare services
Bottom 41% in FL for cardiovascular disease
1,056
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~91 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)402$86$381
Electrocardiogram (EKG), 12-lead285$10$44
EKG interpretation and report236$6$75
Regadenoson injection (Lexiscan) for heart stress test180$42$183
Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days120$20$78
Technetium tc-99m tetrofosmin, diagnostic, per study dose105$339$1,274
Echocardiogram, transthoracic100$143$573
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician60$48$208
Nuclear medicine studies of heart muscle at rest and with stress and spect57$322$1,231
New patient office visit (45-59 min)46$118$499
Remote pacemaker monitoring, 90 days38$23$90
Office visit, established patient, complex (40-54 min)28$123$534
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec27$28$108
Programming of dual lead pacemaker system21$24$110
Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional16$19$77
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.2% high complexity
17.3% medium
73.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$4,733
Total received (2018-2024)
Avg $676/year across 7 years
Top 41% in FL for cardiovascular disease
42
Companies
192
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,733 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$482
2023
$202
2022
$571
2021
$602
2020
$447
2019
$1,534
2018
$895

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABIOMED
$598
Novartis Pharmaceuticals Corporation
$508
Abbott Laboratories
$484
BIOTRONIK INC.
$390
E.R. Squibb & Sons, L.L.C.
$267
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$214
Janssen Pharmaceuticals, Inc
$212
Amgen Inc.
$176
Amarin Pharma Inc.
$166
SANOFI-AVENTIS U.S. LLC
$151
Boston Scientific Corporation
$140
PORTOLA PHARMACEUTICALS, INC.
$136
AstraZeneca Pharmaceuticals LP
$134
PFIZER INC.
$120
Alnylam Pharmaceuticals Inc.
$105
Novo Nordisk Inc
$102
Esperion Therapeutics, Inc.
$100
Cardiovascular Systems Inc.
$70
Corindus Inc.
$53
Kowa Pharmaceuticals America, Inc.
$48
Astellas Pharma US Inc
$46
ATRICURE, INC.
$44
Boehringer Ingelheim Pharmaceuticals, Inc.
$42
Actelion Pharmaceuticals US, Inc.
$39
BOSTON SCIENTIFIC CORPORATION
$39
Regeneron Healthcare Solutions, Inc.
$32
Edwards Lifesciences Corporation
$30
Preventice Services, LLC
$29
Medtronic, Inc.
$28
AtriCure, Inc.
$24
United Therapeutics Corporation
$21
Kiniksa Pharmaceuticals International, plc
$20
ARBOR PHARMACEUTICALS, INC.
$20
Kestra Medical Technology Services, Inc.
$20
PORTOLA PHARMACEUTICALS, LLC
$19
Chiesi USA, Inc.
$19
Impulse Dynamics (USA) Inc.
$18
Lexicon Pharmaceuticals, Inc.
$16
Amryt Pharma Holdings Ltd
$14
Merck Sharp & Dohme Corporation
$14
Gilead Sciences, Inc.
$13
LivaNova USA, Inc.
$11
Top 3 companies account for 33.6% of total payments
Associated products mentioned in payments ›
ANDEXXA · Arcalyst · Assure WCD · BG Mini Plus · BRILINTA · CAMZYOS · CHANTIX · COROFLOW · CardioMEMS HF System · CorPath GRX · Corlanor · Coronary Orbital Atherectomy System · DIAMONDBACK CORONARY · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edarbi · Edwards SAPIEN 3 Transcatheter Heart Valve · FARXIGA · General - Therapies · HeartMate 3 Left Ventricular Dev · Impella · Inpefa · JUXTAPID · KENGREAL · LEQVIO · LEXISCAN · LUX DX · LUX-DX · LifeVest · Livalo · MITRACLIP · MULTAQ · Micra · Mitra Clip system · NEXLETOL · NEXLIZET · ONPATTRO · OPSUMIT · OPTIMIZER · ORENITRAM · Ozempic · PRADAXA · PRALUENT · Peripheral Orbital Atherectomy System · ProtekDuo Kit · RESONATE · Repatha · Rybelsus · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN · Wegovy · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $275 per 100 Medicare services performed
Looking for a cardiovascular disease in Tampa?
Compare cardiovascular diseases in the Tampa area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
225
Per 100K population
15.1
County median income
$75,011
Nearest hospital
ADVENTHEALTH TAMPA
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ohara is a cardiac & electrophysiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ohara experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ohara performed 402 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ohara receive payments from pharmaceutical companies?
Yes. Dr. Ohara received a total of $4,733 from 42 companies across 192 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ohara's costs compare to other cardiovascular diseases in Tampa?
Dr. Ohara's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ohara) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →